Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 47.25
+1.10 (2.38%)
Apr 17, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 75.60 billion as of April 16, 2025. Its market cap has increased by 22.29% in one year.
Market Cap
75.60B
Enterprise Value
70.23B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
47.25
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 75.60B, an increase of 307.80%. That is a compound annual growth rate of 24.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 199.57B |
| Hansoh Pharmaceutical Group Company | 131.45B |
| JD Health International | 111.35B |
| WuXi Biologics | 81.77B |
| Akeso | 78.72B |
| Alibaba Health Information Technology | 73.82B |
| Sino Biopharmaceutical | 66.56B |
| Sichuan Kelun-Biotech Biopharmaceutical | 65.68B |